Molly Harper - Nov 27, 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ Molly Harper
Stock symbol
CPRX
Transactions as of
Nov 27, 2024
Transactions value $
-$283,850
Form type
4
Date filed
11/29/2024, 08:09 PM
Previous filing
Nov 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $101K +17.5K $5.78 17.5K Nov 27, 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$385K -17.5K -100% $22.00 0 Nov 27, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -17.5K -11.55% $0.00 134K Nov 27, 2024 Common Stock 17.5K $5.78 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons and to fund the exercise price of the stock options, and not as a result of any disagreement with the Company.
F2 Options vested in three annual tranches beginning on June 29, 2022.